Press

READ MORE

ETAS®: A Different Way to Think About Stress and Sleep

Published: October 22, 2026

“A Hot Spring in a Capsule for Stress and Sleep”

Maypro’s Lauren Clardy explains how ETAS® supports the body’s heat shock protein response, offering a different approach to the stress-and-sleep category.



READ MORE

Supplement Shorts: Beauty-from-within surges with new science, finished products

Published: October 16, 2026

“Beauty-From-Within Leads a Busy Week in Supplements”

SupplySide Supplement Journal’s weekly roundup covers new beauty research, bone and gut health studies, and Maypro’s exclusive U.S. distribution deal for Aspurus.



READ MORE

Ingredient innovations to watch: A SupplySide Global preview

Published: October 15, 2026

“What to Watch at SupplySide Global 2026”

SupplySide Supplement Journal rounds up standout ingredient launches and research for the show, including new PMOS findings for Maypro’s AKK Probio.




READ MORE

Ingredient Idol 2026 finalists announced

Published: October 14, 2026

“CLB101 Steps Onto the Ingredient Idol Stage”

Maypro’s butyrate-producing probiotic CLB101 is a biotic finalist in SupplySide Supplement Journal’s Ingredient Idol 2026, pitched live at SupplySide Global.



READ MORE

Postbiotic Akkermansia Supports Metabolic, Endocrine, Microbiome Benefits in Women with PMOS: Study

Published: October 14, 2026

“Akkermansia Shows Broad Benefits in PMOS Research”

A 12-week trial found Maypro’s AKK Probio, added to standard therapy, improved insulin, hormone and microbiome measures in women with PMOS.



READ MORE

Maypro Secures Exclusive U.S. Distribution Rights for Aspurus Shatavari

Published: October 13, 2026

“A Full-Spectrum Shatavari for Every Stage of Women’s Health”

Maypro becomes the exclusive U.S. distributor of Aspurus, a clinically studied shatavari extract backed by new perimenopause research in 150 women.




READ MORE

Beyond the Symptom: How Botanicals Are Redefining the Sleep Health Category

Published: October 9, 2026

“Sleep Support Gets to the Root of Restless Nights”

Nutritional Outlook explores how botanicals like saffron, ashwagandha and asparagus extract target stress and cortisol, featuring Maypro’s SaffonX, Venetron and ETAS.



READ MORE

Maypro CEO May Yamada-Lifton on Balancing Legacy With the Future of Consumer Health

Published: October 6, 2026

“Maypro Nears 50: A CEO’s Playbook for Science, AI, and Partnership”

CEO May Yamada-Lifton explains how Maypro plans to stand out in a crowded supplement market, from brand partnerships and growth categories to AI and cross-border collaboration.



READ MORE

2026 NIE New Ingredient Awards

Published: October 1, 2026

“AKK Probio Takes Silver in NIE’s 2026 Weight Management Field”

Nutrition Industry Executive’s annual awards name 14 standout ingredients across seven categories, with Maypro’s AKK Probio placing second for weight management support.




READ MORE

Nutritional Outlook — AKK PROBIO Becomes First Gut-Derived Akkermansia muciniphila Strain to Clear FDA New Dietary Ingredient Review

Published: August 18, 2026

“AKK PROBIO Marks a Major FDA Milestone for Akkermansia”

AKK PROBIO clears the FDA’s New Dietary Ingredient review, marking a regulatory milestone for gut-derived Akkermansia muciniphila as research into its potential benefits continues to grow.



READ MORE

SupplySide Supplement Journal — From digestive health to whole-body wellness: Ingredient lessons learned from probiotics

Published: July 30, 2026

“From Gut Health to Whole-Body Wellness: How Science Expanded the Probiotic Story”

Probiotics have evolved beyond digestive health into whole-body wellness. Maypro’s Abhijit Natu explains how science, consumer insights, and targeted storytelling are driving the next generation of supplement innovation.



READ MORE

ClostraBio Announces Positive Results in Landmark Clinical Study with Next-Generation Probiotic CLB101™ and NutraIngredients USA 2026 Award

Published: July 22, 2026

“Butyrate’s Big Moment: A Next-Generation Probiotic Clears Its First Clinical Trial”

ClostraBio’s CLB101 met safety and efficacy marks in a placebo-controlled study, while the first product built on the strain took a top microbiome award in Chicago.




1 2 3 … 12 Next →